Table of Contents
Chapter 1.Global Inhaled Nitric Oxide Market Definition and Research Assumptions
1.1.Research Objective
1.2.Market Definition
1.3.Research Assumptions
1.3.1.Inclusion & Exclusion
1.3.2.Limitations
1.3.3.Supply Side Analysis
1.3.3.1.Availability
1.3.3.2.Infrastructure
1.3.3.3.Regulatory Environment
1.3.3.4.Market Competition
1.3.3.5.Economic Viability (Consumer's Perspective)
1.3.4.Demand Side Analysis
1.3.4.1.Regulatory frameworks
1.3.4.2.Technological Advancements
1.3.4.3.Environmental Considerations
1.3.4.4.Consumer Awareness & Acceptance
1.4.Estimation Methodology
1.5.Years Considered for the Study
1.6.Currency Conversion Rates
Chapter 2.Executive Summary
2.1.Global Inhaled Nitric Oxide Market Size & Forecast (2022- 2032)
2.2.Regional Summary
2.3.Segmental Summary
2.3.1.By Application
2.4.Key Trends
2.5.Recession Impact
2.6.Analyst Recommendation & Conclusion
Chapter 3.Global Inhaled Nitric Oxide Market Dynamics
3.1.Market Drivers
3.2.Market Challenges
3.3.Market Opportunities
Chapter 4.Global Inhaled Nitric Oxide Market: Industry Analysis
4.1.Porter's 5 Force Model
4.1.1.Bargaining Power of Suppliers
4.1.2.Bargaining Power of Buyers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.1.6.Futuristic Approach to Porter's 5 Force Model
4.1.7.Porter's 5 Force Impact Analysis
4.2.PESTEL Analysis
4.2.1.Political
4.2.2.Economic
4.2.3.Social
4.2.4.Technological
4.2.5.Environmental
4.2.6.Legal
4.3.Top investment opportunity
4.4.Top winning strategies
4.5.Disruptive Trends
4.6.Industry Expert Perspective
4.7.Analyst Recommendation & Conclusion
Chapter 5.Global Inhaled Nitric Oxide Market Size & Forecasts by Application 2022-2032
5.1.Neonatal Respiratory Treatment
5.2.Chronic Obstructive Pulmonary Disease
5.3.Acute Respiratory Distress Syndrome
5.4.Others
Chapter 6.Global Inhaled Nitric Oxide Market Size & Forecasts by Region 2022-2032
6.1.North America Inhaled Nitric Oxide Market
6.1.1.U.S. Inhaled Nitric Oxide Market
6.1.1.1. Application breakdown size & forecasts, 2022-2032
6.1.2.Canada Inhaled Nitric Oxide Market
6.2.Europe Inhaled Nitric Oxide Market
6.2.1.U.K. Inhaled Nitric Oxide Market
6.2.2.Germany Inhaled Nitric Oxide Market
6.2.3.France Inhaled Nitric Oxide Market
6.2.4.Spain Inhaled Nitric Oxide Market
6.2.5.Italy Inhaled Nitric Oxide Market
6.2.6.Rest of Europe Inhaled Nitric Oxide Market
6.3.Asia-Pacific Inhaled Nitric Oxide Market
6.3.1.China Inhaled Nitric Oxide Market
6.3.2.India Inhaled Nitric Oxide Market
6.3.3.Japan Inhaled Nitric Oxide Market
6.3.4.Australia Inhaled Nitric Oxide Market
6.3.5.South Korea Inhaled Nitric Oxide Market
6.3.6.Rest of Asia Pacific Inhaled Nitric Oxide Market
6.4.Latin America Inhaled Nitric Oxide Market
6.4.1.Brazil Inhaled Nitric Oxide Market
6.4.2.Mexico Inhaled Nitric Oxide Market
6.4.3.Rest of Latin America Inhaled Nitric Oxide Market
6.5.Middle East & Africa Inhaled Nitric Oxide Market
6.5.1. Saudi Arabia Inhaled Nitric Oxide Market
6.5.2. South Africa Inhaled Nitric Oxide Market
6.5.3.Rest of Middle East & Africa Inhaled Nitric Oxide Market
Chapter 7.Competitive Intelligence
7.1.Key Company SWOT Analysis
7.2.Top Market Strategies
7.3.Company Profiles
7.3.1.Air Liquide Healthcare (France)
7.3.1.1.Key Information
7.3.1.2.Overview
7.3.1.3.Financial (Subject to Data Availability)
7.3.1.4.Product Summary
7.3.1.5.Market Strategies
7.3.2.SOL Group (Italy)
7.3.3.Matheson Tri-Gas Inc. (United States)
7.3.4.Merck KGaA (Germany)
7.3.5.Mallinckrodt Pharmaceuticals (United Kingdom)
7.3.6.Nu-Med Plus Inc. (United States)
7.3.7.Perma Pure LLC (United States)
7.3.8.Praxair Distribution Inc. (United States)
7.3.9.HALMA PLC (United Kingdom)
7.3.10.LINDE PLC (Germany)
Chapter 8.Research Process
8.1.Research Process
8.1.1.Data Mining
8.1.2.Analysis
8.1.3.Market Estimation
8.1.4.Validation
8.1.5.Publishing
8.2.Research Attributes